Benitec Biopharma Inc. (BNTC): Price and Financial Metrics
BNTC Price/Volume Stats
| Current price | $15.43 | 52-week high | $15.97 |
| Prev. close | $15.52 | 52-week low | $4.75 |
| Day low | $14.90 | Volume | 59,029 |
| Day high | $15.85 | Avg. volume | 34,271 |
| 50-day MA | $11.71 | Dividend yield | N/A |
| 200-day MA | $10.09 | Market Cap | 361.85M |
BNTC Stock Price Chart Interactive Chart >
Benitec Biopharma Inc. (BNTC) Company Bio
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy and chronic hepatitis B virus infection. The company was founded in 1995 and is headquartered in Hayward, California.
BNTC Price Returns
| 1-mo | N/A |
| 3-mo | 26.79% |
| 6-mo | 65.91% |
| 1-year | 204.34% |
| 3-year | -57.19% |
| 5-year | -79.83% |
| YTD | 22.17% |
| 2024 | 291.02% |
| 2023 | 11.76% |
| 2022 | -93.51% |
| 2021 | -12.67% |
| 2020 | -60.78% |
Continue Researching BNTC
Want to see what other sources are saying about Benitec Biopharma LTD's financials and stock price? Try the links below:Benitec Biopharma LTD (BNTC) Stock Price | Nasdaq
Benitec Biopharma LTD (BNTC) Stock Quote, History and News - Yahoo Finance
Benitec Biopharma LTD (BNTC) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...